NOVEL DIPHENYLMETHANE DERIVATIVES AS SGLT2 INHIBITORS
First Claim
Patent Images
1. A compound of formula I, or a pharmaceutically acceptable salt or a prodrug thereof:
1 Assignment
0 Petitions
Accused Products
Abstract
A compound with a diphenylmethane moiety having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney is disclosed. A pharmaceutical composition including the compound as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes is disclosed. A method for preparing the compound, and a method for preventing or treating metabolic disorders, particularly diabetes, by using the compound is provided.
4 Citations
14 Claims
- 1. A compound of formula I, or a pharmaceutically acceptable salt or a prodrug thereof:
Specification